Citadel Advisors’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,900
Closed -$494K 13856
2025
Q4
$494K Buy
10,900
+1,100
+11% +$40.2K ﹤0.01% 9053
2025
Q3
$298K Sell
9,800
-9,900
-50% -$304K ﹤0.01% 10383
2025
Q2
$579K Sell
19,700
-7,000
-26% -$209K ﹤0.01% 8304
2025
Q1
$933K Buy
26,700
+6,800
+34% +$270K ﹤0.01% 7112
2024
Q4
$886K Sell
19,900
-7,100
-26% -$319K ﹤0.01% 7300
2024
Q3
$1.18M Buy
27,000
+10,500
+64% +$396K ﹤0.01% 6533
2024
Q2
$447K Buy
16,500
+3,800
+30% +$110K ﹤0.01% 8284
2024
Q1
$371K Buy
12,700
+2,400
+23% +$72.8K ﹤0.01% 9006
2023
Q4
$388K Sell
10,300
-24,500
-70% -$901K ﹤0.01% 8635
2023
Q3
$1.57M Sell
34,800
-25,200
-42% -$1.53M ﹤0.01% 5667
2023
Q2
$4.42M Buy
60,000
+42,200
+237% +$2.85M ﹤0.01% 3835
2023
Q1
$1.04M Buy
17,800
+8,900
+100% +$491K ﹤0.01% 6688
2022
Q4
$449K Sell
8,900
-29,300
-77% -$1.76M ﹤0.01% 8472
2022
Q3
$3.33M Buy
38,200
+23,700
+163% +$2.49M ﹤0.01% 4596
2022
Q2
$1.65M Buy
14,500
+4,100
+39% +$471K ﹤0.01% 5945
2022
Q1
$1.35M Buy
10,400
+600
+6% +$86.5K ﹤0.01% 6995
2021
Q4
$1.77M Buy
9,800
+5,400
+123% +$937K ﹤0.01% 6531
2021
Q3
$653K Sell
4,400
-15,700
-78% -$2.41M ﹤0.01% 9240
2021
Q2
$3.04M Sell
20,100
-1,100
-5% -$153K ﹤0.01% 5566
2021
Q1
$2.75M Sell
21,200
-9,400
-31% -$1.21M ﹤0.01% 5645
2020
Q4
$3.67M Buy
30,600
+8,900
+41% +$873K ﹤0.01% 4228
2020
Q3
$1.62M Buy
21,700
+9,300
+75% +$645K ﹤0.01% 5125
2020
Q2
$876K Buy
12,400
+7,500
+153% +$513K ﹤0.01% 6063
2020
Q1
$321K Sell
4,900
-3,000
-38% -$239K ﹤0.01% 7209
2019
Q4
$646K Sell
7,900
-6,900
-47% -$529K ﹤0.01% 6385
2019
Q3
$1.07M Sell
14,800
-400
-3% -$29.4K ﹤0.01% 5485
2019
Q2
$1.31M Buy
15,200
+8,600
+130% +$699K ﹤0.01% 5269
2019
Q1
$534K Sell
6,600
-600
-8% -$44.9K ﹤0.01% 6677
2018
Q4
$441K Sell
7,200
-3,200
-31% -$217K ﹤0.01% 6592
2018
Q3
$748K Sell
10,400
-3,500
-25% -$220K ﹤0.01% 6037
2018
Q2
$729K Buy
+13,900
New +$654K ﹤0.01% 5756
2018
Q1
Sell
-6,700
Closed -$325K 8630
2017
Q4
$325K Buy
+6,700
New +$338K ﹤0.01% 6329
2016
Q1
Sell
-1,500
Closed -$47K 7616
2015
Q4
$47K Sell
1,500
-2,300
-61% -$67.9K ﹤0.01% 7370
2015
Q3
$118K Sell
3,800
-3,100
-45% -$111K ﹤0.01% 6795
2015
Q2
$260K Buy
6,900
+5,600
+431% +$204K ﹤0.01% 5951
2015
Q1
$46K Buy
1,300
+1,200
+1,200% +$39.6K ﹤0.01% 7431
2014
Q4
$3K Buy
+100
New +$3.09K ﹤0.01% 8338
2014
Q2
Sell
-2,300
Closed -$66K 8199
2014
Q1
$66K Buy
2,300
+300
+15% +$8.21K ﹤0.01% 6538
2013
Q4
$51K Sell
2,000
-100
-5% -$2.39K ﹤0.01% 6021
2013
Q3
$50K Sell
2,100
-9,600
-82% -$214K ﹤0.01% 5792
2013
Q2
$240K Buy
+11,700
New +$216K ﹤0.01% 4502

Other funds holding OMCL

Citadel Advisors's OMCL Position: Q1 2026 in Review

Citadel Advisors sold out of Omnicell (OMCL) in Q1 2026, closing a stake of 252,062 shares — an estimated $11.4M sold.

Citadel Advisors first reported a position in OMCL in Q2 2013 and held it in 39 quarters. The position peaked at $30.2M in Q3 2022. 272 funds tracked by Wall St. Rank hold OMCL as of Q1 2026.

  • Citadel Advisors reported no remaining Omnicell position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 252,062 Omnicell shares in Q1 2026, an estimated $11.4M.
  • Citadel Advisors first reported a position in Omnicell in Q2 2013 and held it in 39 quarters.
  • Citadel Advisors's Omnicell position peaked at $30.2M in Q3 2022.
  • 272 funds tracked by Wall St. Rank held Omnicell as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.